Detailed TOC of Global Prostate Cancer Drugs Market Outlook 2025
1 Prostate Cancer Drugs Market Overview
1.1 Product Overview and Scope of Prostate Cancer Drugs
1.2 Prostate Cancer Drugs Segment by Type
1.2.1 Global Prostate Cancer Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Hormonal Therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Targeted Therapy
1.3 Prostate Cancer Drugs Segment by Application
1.3.1 Global Prostate Cancer Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Global Prostate Cancer Drugs Market Size Estimates and Forecasts
1.4.1 Global Prostate Cancer Drugs Revenue 2016-2027
1.4.2 Global Prostate Cancer Drugs Sales 2016-2027
1.4.3 Prostate Cancer Drugs Market Size by Region: 2016 Versus 2021 Versus 2027
2 Prostate Cancer Drugs Market Competition by Manufacturers
2.1 Global Prostate Cancer Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Prostate Cancer Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Prostate Cancer Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Prostate Cancer Drugs Manufacturing Sites, Area Served, Product Type
2.5 Prostate Cancer Drugs Market Competitive Situation and Trends
2.5.1 Prostate Cancer Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Prostate Cancer Drugs Players Market Share by Revenue
2.5.3 Global Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prostate Cancer Drugs Retrospective Market Scenario by Region
3.1 Global Prostate Cancer Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Prostate Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Prostate Cancer Drugs Market Facts & Figures by Country
3.3.1 North America Prostate Cancer Drugs Sales by Country
3.3.2 North America Prostate Cancer Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Prostate Cancer Drugs Market Facts & Figures by Country
3.4.1 Europe Prostate Cancer Drugs Sales by Country
3.4.2 Europe Prostate Cancer Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Prostate Cancer Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Prostate Cancer Drugs Sales by Region
3.5.2 Asia Pacific Prostate Cancer Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Prostate Cancer Drugs Market Facts & Figures by Country
3.6.1 Latin America Prostate Cancer Drugs Sales by Country
3.6.2 Latin America Prostate Cancer Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Prostate Cancer Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Prostate Cancer Drugs Sales by Country
3.7.2 Middle East and Africa Prostate Cancer Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Prostate Cancer Drugs Historic Market Analysis by Type
4.1 Global Prostate Cancer Drugs Sales Market Share by Type (2016-2021)
4.2 Global Prostate Cancer Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Prostate Cancer Drugs Price by Type (2016-2021)
5 Global Prostate Cancer Drugs Historic Market Analysis by Application
5.1 Global Prostate Cancer Drugs Sales Market Share by Application (2016-2021)
5.2 Global Prostate Cancer Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Prostate Cancer Drugs Price by Application (2016-2021)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AbbVie Prostate Cancer Drugs Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Astellas Pharma
6.2.1 Astellas Pharma Corporation Information
6.2.2 Astellas Pharma Description and Business Overview
6.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Astellas Pharma Prostate Cancer Drugs Product Portfolio
6.2.5 Astellas Pharma Recent Developments/Updates
6.3 Astra Zeneca
6.3.1 Astra Zeneca Corporation Information
6.3.2 Astra Zeneca Description and Business Overview
6.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Astra Zeneca Prostate Cancer Drugs Product Portfolio
6.3.5 Astra Zeneca Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Johnson & Johnson Prostate Cancer Drugs Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Sanofi Prostate Cancer Drugs Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 GlaxoSmithKline Prostate Cancer Drugs Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Merck Group
6.6.1 Merck Group Corporation Information
6.6.2 Merck Group Description and Business Overview
6.6.3 Merck Group Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck Group Prostate Cancer Drugs Product Portfolio
6.7.5 Merck Group Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Corporation Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Novartis Prostate Cancer Drugs Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Amgen
6.9.1 Amgen Corporation Information
6.9.2 Amgen Description and Business Overview
6.9.3 Amgen Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Amgen Prostate Cancer Drugs Product Portfolio
6.9.5 Amgen Recent Developments/Updates
6.10 Bayer HealthCare
6.10.1 Bayer HealthCare Corporation Information
6.10.2 Bayer HealthCare Description and Business Overview
6.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Bayer HealthCare Prostate Cancer Drugs Product Portfolio
6.10.5 Bayer HealthCare Recent Developments/Updates
6.11 Ferring Pharmaceutical
6.11.1 Ferring Pharmaceutical Corporation Information
6.11.2 Ferring Pharmaceutical Prostate Cancer Drugs Description and Business Overview
6.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Ferring Pharmaceutical Prostate Cancer Drugs Product Portfolio
6.11.5 Ferring Pharmaceutical Recent Developments/Updates
6.12 Janssen Pharmaceuticals
6.12.1 Janssen Pharmaceuticals Corporation Information
6.12.2 Janssen Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Janssen Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.12.5 Janssen Pharmaceuticals Recent Developments/Updates
6.13 Endo Pharmaceuticals
6.13.1 Endo Pharmaceuticals Corporation Information
6.13.2 Endo Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Endo Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.13.5 Endo Pharmaceuticals Recent Developments/Updates
6.14 BMS
6.14.1 BMS Corporation Information
6.14.2 BMS Prostate Cancer Drugs Description and Business Overview
6.14.3 BMS Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.14.4 BMS Prostate Cancer Drugs Product Portfolio
6.14.5 BMS Recent Developments/Updates
6.15 Takeda Pharmaceuticals
6.15.1 Takeda Pharmaceuticals Corporation Information
6.15.2 Takeda Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Takeda Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.15.5 Takeda Pharmaceuticals Recent Developments/Updates
6.16 Northwest Biotherapeutics
6.16.1 Northwest Biotherapeutics Corporation Information
6.16.2 Northwest Biotherapeutics Prostate Cancer Drugs Description and Business Overview
6.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Northwest Biotherapeutics Prostate Cancer Drugs Product Portfolio
6.16.5 Northwest Biotherapeutics Recent Developments/Updates
6.17 Teva Pharmaceutical
6.17.1 Teva Pharmaceutical Corporation Information
6.17.2 Teva Pharmaceutical Prostate Cancer Drugs Description and Business Overview
6.17.3 Teva Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Teva Pharmaceutical Prostate Cancer Drugs Product Portfolio
6.17.5 Teva Pharmaceutical Recent Developments/Updates
6.18 Boehringer Ingelheim
6.18.1 Boehringer Ingelheim Corporation Information
6.18.2 Boehringer Ingelheim Prostate Cancer Drugs Description and Business Overview
6.18.3 Boehringer Ingelheim Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Boehringer Ingelheim Prostate Cancer Drugs Product Portfolio
6.18.5 Boehringer Ingelheim Recent Developments/Updates
6.19 Foresee Pharmaceuticals
6.19.1 Foresee Pharmaceuticals Corporation Information
6.19.2 Foresee Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Foresee Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.19.5 Foresee Pharmaceuticals Recent Developments/Updates
6.20 Tokai Pharmaceuticals
6.20.1 Tokai Pharmaceuticals Corporation Information
6.20.2 Tokai Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Tokai Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.20.5 Tokai Pharmaceuticals Recent Developments/Updates
6.21 Spectrum Pharmaceuticals
6.21.1 Spectrum Pharmaceuticals Corporation Information
6.21.2 Spectrum Pharmaceuticals Prostate Cancer Drugs Description and Business Overview
6.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Spectrum Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.21.5 Spectrum Pharmaceuticals Recent Developments/Updates
7 Prostate Cancer Drugs Manufacturing Cost Analysis
7.1 Prostate Cancer Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Prostate Cancer Drugs
7.4 Prostate Cancer Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Prostate Cancer Drugs Distributors List
8.3 Prostate Cancer Drugs Customers
9 Prostate Cancer Drugs Market Dynamics
9.1 Prostate Cancer Drugs Industry Trends
9.2 Prostate Cancer Drugs Growth Drivers
9.3 Prostate Cancer Drugs Market Challenges
9.4 Prostate Cancer Drugs Market Restraints
10 Global Market Forecast
10.1 Prostate Cancer Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Prostate Cancer Drugs by Type (2025-2027)
10.1.2 Global Forecasted Revenue of Prostate Cancer Drugs by Type (2025-2027)
10.2 Prostate Cancer Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Prostate Cancer Drugs by Application (2025-2027)
10.2.2 Global Forecasted Revenue of Prostate Cancer Drugs by Application (2025-2027)
10.3 Prostate Cancer Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Prostate Cancer Drugs by Region (2025-2027)
10.3.2 Global Forecasted Revenue of Prostate Cancer Drugs by Region (2025-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
